Metabolic Outcomes of Percutaneous Transcathether Bariatric Embolotherapy: Insights from an RCT
- PMID: 33606185
- DOI: 10.1007/s11695-021-05259-3
Metabolic Outcomes of Percutaneous Transcathether Bariatric Embolotherapy: Insights from an RCT
References
-
- Reddy VY, Neužil P, Musikantow D, et al. Transcatheter bariatric embolotherapy for weight reduction in obesity. J Am Coll Cardiol. 2020;76(20):2305–17. - DOI
-
- Pareek M, Bhatt DL, Nielsen ML, et al. Enhanced predictive capability of a 1-hour oral glucose tolerance test: a prospective population-based cohort study. Diabetes Care. 2018;41(1):171–7. - DOI
-
- Alyass A, Almgren P, Akerlund M, et al. Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia. 2015;58(1):87–97. - DOI
-
- Jagannathan R, Sevick MA, Fink D, et al. The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia. Acta Diabetol. 2016;53(4):543–50. - DOI
-
- Peddinti G, Bergman M, Tuomi T, et al. 1-hour post-OGTT glucose improves the early prediction of type 2 diabetes by clinical and metabolic markers. J Clin Endocrinol Metab. 2019;104(4):1131–40. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical